The Sri Lanka-Cambridge Paediatric Cancer Partnership was established in 2025 with the aim of improving outcomes for children with cancer, supporting the World Health Organisation’s objective of achieving at least 60% survival for all children with cancer by 2030. The partnership is a collaboration between the National Cancer Institute of Sri Lanka (NCISL), also known as Apeksha Hospital, Cambridge University Hospitals NHS Foundation Trust (CUH) and Cambridge Global Health Partnerships (CGHP).
NCISL is the country’s leading centre for cancer care and home to a well-established paediatric oncology service that cares for around 800 children with cancer each year. Through this partnership, experts from NCISL and CUH are working together to strengthen specialist skills, clinical practice and support services, with the shared goal of improving outcomes for children with cancer in Sri Lanka and the UK.
Through a targeted programme of training, mentorship and co-development of evidence-informed clinical protocols and services, the partnership is focusing on three key areas:
- Strengthening specialist knowledge and skills, with a particular focus on a multidisciplinary approach to care and on enhancing paediatric nursing capacity.
- Refining and enhancing clinical protocols, supporting safer, more consistent and effective care.The partnership is also exploring the use of genomic testing to enable earlier and more accurate diagnosis.
- Establishing a programme of education and support for families and carers, helping to build knowledge, confidence and peer support among families.
With your generous support, this partnership can continue to improve patient outcomes while creating lasting opportunities for reciprocal learning, innovation and professional development for both institutions and the healthcare professionals involved.
Contributions will be used only for the partnership’s operational expenses and not for the supply of medicines or equipment to NCISL.
I’d like to give…
“This partnership is built on a shared commitment to improving outcomes for children with cancer. By bringing together the knowledge, experience and perspectives of teams in Sri Lanka and Cambridge, we can learn from one another, strengthen clinical practice and develop approaches to care that benefit children, families, and healthcare professionals in both countries. “
Sanjeeva Gunasekera, Paediatric and Adolescent Clinical Oncology Specialist, National Cancer Institute Sri Lanka
